Piperacillin Prophylaxis in Major Liver and Pancreatic Surgery
Official title: PROPHTAZ: Evaluation of Pharmacokinetic/Pharmacodynamic Target Attainment of Piperacillin During Major Hepatic and Pancreatic Surgery, a Prospective Observational Pharmacokinetic Study
Run by Central Hospital, Nancy, France · NCT07558681 · Data updated 2026-11-12
This study tests whether piperacillin/tazobactam given around surgery reliably reaches the right levels to help prevent infections in adults undergoing major liver or pancreatic surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 2 sites (Vandœuvre-lès-Nancy, Lorraine and 1 other locations) |
| Status | Recruiting |
| Started | September 25, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT07558681 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older scheduled for major hepatic or pancreatic surgery and receiving piperacillin/tazobactam as perioperative prophylaxis.
✕Probably not a fit
Patients who do not experience altered PK/PD for piperacillin during surgery or who do not encounter suboptimal exposure may see no direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study examines the perioperative pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in adults undergoing major hepatic or pancreatic surgery. It focuses on whether standard dosing achieves target drug exposure despite the physiological changes that occur during these operations. The goal is to understand how factors like fluid shifts and hypoalbuminemia affect antibiotic levels during the perioperative period. Data will help determine if current prophylaxis regimens meet PK/PD targets in high-risk surgical patients. No interventional treatment changes are prescribed within the study protocol.
Why it matters
Potential benefit: If successful, the study could inform more reliable perioperative antibiotic dosing to reduce surgical site infections in high-risk liver and pancreas surgeries.
How similar studies have gone: Previous work in antibiotic PK/PD has shown variability in major surgery; this study builds on that by focusing on piperacillin/tazobactam in hepatic/pancreatic procedures.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults \> or = to 18 years old * Scheduled for major hepatic or pancreatic surgery * Receiving piperacillin/tazobactam as perioperative antibiotic prophylaxis according to guidelines Exclusion Criteria: * decline to participate * Known allergy of beta-lactam
Where it's running
-
CHRU de NANCY
Nancy, France Recruiting -
CHRU de Nancy
Vandœuvre-lès-Nancy, Lorraine, France Not yet recruiting
Study contacts
- Study coordinator: Emmanuel NOVY, MD, PhD
- Email: e.novy@chru-nancy.fr
- Phone: +33 383157437
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Which single-dose antibiotic works best to prevent complications after lower wisdom tooth removal
This trial tests whether a single dose of amoxicillin, clindamycin, or azithromycin is best at reducing post-surgery problems for adults undergoing lower wisdom tooth extraction.
-
Antibiotic Prophylaxis Before Simple Tooth Extraction in Immunosuppressed Patients with Autoimmune Rheumatic Diseases
This trial tests whether giving a single dose of amoxicillin before a simple tooth extraction can prevent infections in adults with autoimmune rheumatic diseases who are on immunosuppressive therapy.
-
Adding azithromycin to ampicillin for late PPROM
This test sees if adding a single dose of azithromycin to the usual ampicillin/amoxicillin treatment helps newborns when membranes break early between 34.0 and 36.6 weeks.
-
Cefazolin Prophylaxis and CSF Levels in Ventricular Shunt Surgery
This study tests whether a standard 2 g dose of cefazolin given before ventricular shunt surgery yields enough drug in the brain’s fluid to help prevent valve infections.
-
Understanding antibiotic resistance and microbiome changes in STI prevention
This study is trying to see how using doxycycline for STI prevention affects antibiotic resistance and changes in gut bacteria in men who have sex with men.
-
Testing targeted antibiotics to prevent infections after bladder surgery
This study is testing if using personalized antibiotics based on urine bacteria can help prevent infections after bladder surgery better than standard antibiotics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.